Kotak NIFTY 100 Low Volatility 30 Index Fund
Direct Plan · Growth · Kotak Mahindra Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +0.20% | +0.02% | 85 of 293 |
| 1M | -4.54% | -3.46% | 163 of 293 |
| 3M | -6.30% | -2.90% | 261 of 292 |
| 6M | -3.08% | +1.26% | 217 of 284 |
| YTD | -11.08% | -3.38% | 231 of 293 |
| 1Y | -7.65% | -1.41% | 202 of 266 |
| 2Y | -4.50% | -0.35% | 134 of 188 |
| INCEPTION | +0.18% | — | — |
Ranked among: Other Scheme - Index Funds.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +0.52% | +15.65% | -13.38% | 55% | 21% |
| 6M | +0.37% | +16.67% | -15.04% | 54% | 21% |
| 1Y | +3.12% | +14.09% | -8.40% | 67% | 27% |
| 2Y | +0.10% | +3.48% | -6.15% | 64% | 25% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity99.80%
- Debt0.00%
- Cash0.20%
- Other0.00%
Market Cap Split
- Large Cap96.75%
- Mid Cap3.23%
- Small Cap0.00%
- Others0.02%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 25.99 | 24.20 |
| P/B | 4.08 | 4.00 |
| Price / Sales | 3.41 | 3.37 |
| Price / Cash Flow | 19.79 | 17.82 |
| Dividend Yield (%) | 1.97 | 1.52 |
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| ICICI Bank | Banks | 3.84% | -0.26% |
| Sun Pharmaceutical | Pharmaceuticals and Biotechnology | 3.82% | +0.02% |
| Apollo Hospitals | Equity | 3.81% | +0.11% |
| NTPC | Power | 3.79% | +0.27% |
| Britannia Industries | Food Products | 3.68% | +0.25% |
| Bharti Airtel | Telecom - Services | 3.65% | +0.18% |
| Kotak Bank | Banks | 3.63% | +0.22% |
| SBI Life Insurance | Insurance | 3.62% | +0.06% |
| Nestle | Food Products | 3.53% | -0.21% |
| ITC | Diversified FMCG | 3.50% | +0.35% |
| Reliance Industries | Petroleum Products | 3.47% | +0.16% |
| Tata Power | Power | 3.42% | — |
| Cipla | Pharmaceuticals and Biotechnology | 3.42% | +0.12% |
| Power Grid Corporation of India | Power | 3.39% | — |
| HDFC Bank | Banks | 3.39% | +0.13% |
View all 32 holdings
| Hindustan Unilever | Diversified FMCG | 3.37% | +0.13% |
| Torrent Pharmaceuticals | Pharmaceuticals and Biotechnology | 3.32% | +0.02% |
| HDFC Life Insurance | Insurance | 3.27% | — |
| Dr Reddys Laboratories | Pharmaceuticals and Biotechnology | 3.23% | +0.58% |
| Maruti Suzuki | Automobiles | 3.16% | +0.06% |
| UltraTech Cement | Cement and Cement Products | 3.15% | +0.03% |
| Bajaj Auto | Automobiles | 3.13% | -0.84% |
| State Bank of India | Banks | 3.08% | -0.12% |
| Asian Paints | Consumer Durables | 3.04% | +0.10% |
| Bajaj Finserv | Finance | 3.02% | -0.57% |
| Titan | Consumer Durables | 3.01% | -0.59% |
| Pidilite Industries | Chemicals and Petrochemicals | 2.97% | -0.17% |
| Larsen & Toubro | Construction | 2.86% | +0.11% |
| Wipro | IT - Software | 2.82% | -0.34% |
| Tata Consultancy Services | IT - Software | 2.59% | -1.05% |
| Triparty Repo | Reverse Repo / TREPS | 0.20% | — |
| Net Current Assets/(Liabilities) | Equity | -0.18% | — |
Sector Allocation · Sep 2026
View all 17 sectors
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 11.34 | — | High Volatility |
What is this?
Risk as measured by standard deviation is a statistical measure that quantifies the amount of variation or dispersion in a set of data points relative to its mean (average).
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.53 | — | Poor Risk Adjusted Returns |
What is this?
Higher the value means that fund has been able to give better returns for the amount of risk taken. It helps investors understand the return of an investment compared to its risk, showing whether the returns are due to intelligent investing or simply taking on excess risk. It is calculated by subtracting the risk-free return, defined as an Indian Government Bond, from the fund's returns, and then dividing by the standard deviation of returns.
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.64 | — | Poor Risk Adjusted Returns |
What is this?
The Sortino Ratio is a financial metric used to measure the risk-adjusted return of an investment. It's a modification of the Sharpe Ratio but with a key difference; it only considers downside risk (the risk of negative returns), rather than total volatility. This means it focuses on how well an investment performs relative to the volatility that leads to losses, ignoring the volatility that results in gains. The idea is that investors are primarily concerned with minimizing losses, and positive volatility is generally seen as a good thing.
Tracking Difference
Versus Nifty 100 Low Volatility 30 TRI, as of Sep 2026.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
ICICI Prudential NASDAQ 100 Index Fund
Regular Plan · Growth
|
+33.08% | +33.05% | — | +20.39% |
|
Motilal Oswal S&P 500 Index Fund
Direct Plan · GROWTH
|
+26.67% | +28.18% | +18.46% | +21.68% |
|
ICICI Prudential Nifty Pharma Index Fund
Direct Plan · IDCW
|
+18.49% | +19.85% | — | +20.26% |
|
Tata Nifty Capital Markets Index Fund
Direct Plan · Growth Option
|
+17.70% | — | — | +19.75% |
|
Motilal Oswal Nifty Capital Market Index Fund
Regular Plan · Growth
|
+17.11% | — | — | +13.86% |
|
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund
Direct Plan · Growth
|
+15.99% | +19.01% | +13.57% | +16.01% |
|
Tata Nifty MidSmall Healthcare Index Fund
Regular Plan · IDCW Payout Option
|
+12.58% | — | — | +16.09% |
|
Motilal Oswal Nifty MidSmall Healthcare Index Fund
Regular Plan · Growth
|
+12.54% | — | — | +9.31% |
|
Motilal Oswal Nifty MidSmall Financial Services Index Fund
Regular Plan · Growth
|
+10.45% | — | — | +16.60% |
|
Motilal Oswal Nifty India Defence Index Fund
Regular Plan · Growth
|
+10.29% | — | — | +3.54% |
More From Kotak Mahindra Asset Management Company Limited.
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
| Kotak Silver ETF | +38.66% | +46.06% | — | +34.57% |
|
Kotak Silver ETF Fund of Fund
Direct Plan · Growth
|
+35.68% | +44.78% | — | +34.32% |
|
Kotak US Specific Equity Passive FOF
Direct Plan · Growth
|
+34.01% | +33.87% | +21.82% | +21.55% |
|
Kotak Global Emerging Market Overseas Equity Active FOF
Direct Plan · Growth
|
+33.80% | +28.00% | +12.51% | +9.60% |
|
Kotak Global Innovation Overseas Equity Active FOF
Direct Plan · Growth
|
+28.81% | +27.62% | +11.00% | +10.06% |
|
Kotak Healthcare Fund
Direct Plan · Growth Option
|
+24.38% | — | — | +21.35% |
|
Kotak Gold Fund
Direct Plan · Growth
|
+21.03% | +35.79% | +24.52% | +10.98% |
| KOTAK GOLD ETF | +20.93% | +36.16% | +24.85% | +14.76% |
|
Kotak MNC Fund
Direct Plan · Growth
|
+16.26% | — | — | +11.67% |
|
Kotak Special Opportunities Fund
Direct Plan · Growth
|
+15.76% | — | — | +6.39% |
About This Scheme
Investment Objective
The investment objective of the scheme is to provide returns that, before expenses, corresponding to the total returns of the securities as represented by the underlying index, subject to tracking errors. However, There is no assurance that the investment objective of the Scheme will be achieved
Stated Asset Allocation
Investments Indicative Allocation Equity and Equity related securities covered by NIFTY 100 Low Volatility 30 Index - 95%-100%-Very High Debt/Money Market Instruments -0%-5%-Low to Moderate
Exit Load
Nil
Fund Managers
FM 1 Mr. Satish Dondapati FM 2 Mr. Abhishek Bisen FM 3 Mr. Jeetu Valechha Sonar
FM 1 Fund Manager will be the designated Fund Managers for the Scheme. FM 2 Fund Manager will be the Fund Manager for debt securities of the Scheme.FM 3 Fund Manager will be the designated Fund Managers for the Scheme.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch